Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Hookipa Pharma Inc
HOOK

Buy HOOK Stock

HOOK
See HOOK stock price and Buy/Sell Hookipa Pharma Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
HOOK

Hookipa Pharma Inc (HOOK)

About Hookipa Pharma Inc (HOOK)

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its product includes VaxWace and TheraT. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, Katherine Cohen, and Daniel Pinschewer in 2011 and is headquartered...Read more
Market Cap
$89.72M
1 Year High
$7.09
Volume
71.72k
1 Year Low
$1.25
Price to Earnings Ratio
Open
$1.63
Dividend Rate
High
$1.64
Dividend Yield
Low
$1.58

Community

People who own or watch HOOK stock

HOOK Stock News

HOOK stock rating

What analysts recommend for HOOK stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.3

HOOK price target

What analysts think HOOK will be worth
Low $1.25
High $7.75
Current $1.62
Target $7.75

Events

List of events that could affect HOOK stock.
11Aug

Earnings data Q2 2022

09Nov

Earnings data Q3 2022

HOOK earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.23
-0.45
-0.68
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
-$0.30
Actual EPS
Q3 2022

Buy HOOK Stock

HOOK
See HOOK stock price and Buy/Sell Hookipa Pharma Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch HOOK stock
  • Ezeoke avatar
  • bryn avatar
  • sharkteeth621 avatar
  • joey2tec avatar
  • coilprep8 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.